"Pro Medicus is a medical imaging software company, generating sales from its Visage product across North America and Europe as well as Asia-Pacific. The business generates revenue on a 'pay-per-click' basis, with guaranteed transaction minimums over contracts of five years or more.Morgans forecast significant revenue growth, margin and dividend expansion over coming years. The broker initiates coverage with an Add rating and $23.69 target.Sector: Health Care Equipment & Services.Target price is $23.69.Current Price is $20.47. Difference: $3.22 - (brackets indicate current price is over target). If PME meets the Morgans target it will return approximately 14% (excluding dividends, fees and charges - negative figures indicate an expected loss)."
PME Price at posting:
$21.20 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)